{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:20:33Z","timestamp":1791181233851,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>This study aimed to investigate rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) status and levels as predictors of mortality in two large cohorts of patients with early inflammatory arthritis (EIA).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Data from the Norfolk Arthritis Register (NOAR) and Leiden Early Arthritis Clinic (EAC) cohorts were used. At baseline, patients had demographic data and smoking status recorded; RF, ACPA and inflammatory markers were measured in the local laboratories. Patients were flagged with national death registers until death or censor date. Antibody status was stratified as negative, low or high positive by RF and ACPA levels individually. In addition, patients were grouped as seronegative, RF positive, ACPA positive or double antibody (RF and ACPA) positive. Cox regression models explored associations between antibody status and mortality adjusting for age, sex, smoking status, inflammatory markers and year of enrolment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>A total of 4962 patients were included, 64% were female. Median age at onset was 56 (NOAR) and 54 (EAC) years. In NOAR and EAC respectively, 35% and 42% of patients were ACPA\/RF positive. When antibody status was stratified as negative, low or high positive, there were no consistent findings between the two cohorts. Double antibody positivity was associated with excess mortality in both cohorts compared to seronegative patients: NOAR and EAC respective adjusted HR (95% confidence interval) 1.35 (1.09 to 1.68) and 1.58 (1.16 to 2.15).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Patients with EIA who are seropositive for both RF and ACPA have increased mortality compared to those who are single positive or seronegative. Antibody level in seropositive patients was not consistently associated with excess mortality.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0483-3","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T17:46:56Z","timestamp":1417456016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts"],"prefix":"10.1186","volume":"16","author":[{"given":"Jennifer H","family":"Humphreys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica AB","family":"van Nies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Chipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarnya","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette HM","family":"van der Helm-van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah PM","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne MM","family":"Verstappen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","volume":"45","author":"MA Quinn","year":"2006","unstructured":"Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, Fraser A, Emery P: Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology. 2006, 45: 478-480. 10.1093\/rheumatology\/kei203.","journal-title":"Rheumatology"},{"key":"483_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L De Rycke","year":"2004","unstructured":"De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F: Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004, 63: 1587-1593. 10.1136\/ard.2003.017574.","journal-title":"Ann Rheum Dis"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Ronnelid","year":"2005","unstructured":"Ronnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF: Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5\u00a0year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005, 64: 1744-1749. 10.1136\/ard.2004.033571.","journal-title":"Ann Rheum Dis"},{"key":"483_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10067-007-0558-5","volume":"26","author":"E Kudo-Tanaka","year":"2007","unstructured":"Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y: Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol. 2007, 26: 1627-1633. 10.1007\/s10067-007-0558-5.","journal-title":"Clin Rheumatol"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/ard.2008.088401","volume":"68","author":"WH Bos","year":"2009","unstructured":"Bos WH, Bartelds GM, Vis M, van der Horst AR, Wolbink GJ, Van De Stadt RJ, Van Schaardenburg D, Dijkmans BA, Lems WF, Nurmohamed MT, Aarden L, Hamann D: Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis. Ann Rheum Dis. 2009, 68: 558-563. 10.1136\/ard.2008.088401.","journal-title":"Ann Rheum Dis"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/ar4148","volume":"15","author":"N Bizzaro","year":"2013","unstructured":"Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, Filippini M, Tampoia M, Afeltra A, Sebastiani G, Alpini C, Bini V, Bistoni O, Alunno A, Gerli R: Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. Arthritis Res Ther. 2013, 15: R16-10.1186\/ar4148.","journal-title":"Arthritis Res Ther"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/ar2995","volume":"12","author":"MD Mjaavatten","year":"2010","unstructured":"Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK: The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis. Arthritis Res Ther. 2010, 12: R76-10.1186\/ar2995.","journal-title":"Arthritis Res Ther"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12016-007-8018-1","volume":"34","author":"NG Papadopoulos","year":"2008","unstructured":"Papadopoulos NG, Tsiaousis GZ, Pavlitou-Tsiontsi A, Giannakou A, Galanopoulou VK: Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients?. Clin Rev Allergy Immunol. 2008, 34: 11-15. 10.1007\/s12016-007-8018-1.","journal-title":"Clin Rev Allergy Immunol"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3899\/jrheum.111152","volume":"39","author":"K Shiozawa","year":"2012","unstructured":"Shiozawa K, Kawasaki Y, Yamane T, Yoshihara R, Tanaka Y, Uto K, Shiozawa S: Anticitrullinated protein antibody, but not its titer, is a predictor of radiographic progression and disease activity in rheumatoid arthritis. J Rheumatol. 2012, 39: 694-700. 10.3899\/jrheum.111152.","journal-title":"J Rheumatol"},{"key":"483_CR10","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/ar2907","volume":"12","author":"J Ursum","year":"2010","unstructured":"Ursum J, Bos WH, van Dillen N, Dijkmans BA, Van Schaardenburg D: Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study. Arthritis Res Ther. 2010, 12: R8-10.1186\/ar2907.","journal-title":"Arthritis Res Ther"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/annrheumdis-2012-202615","volume":"73","author":"P Suwannalai","year":"2014","unstructured":"Suwannalai P, Britsemmer K, Knevel R, Scherer HU, Levarht EW, van der Helm-van Mil AH, Van Schaardenburg D, Huizinga TW, Toes RE, Trouw LA: Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2014, 73: 720-726. 10.1136\/annrheumdis-2012-202615.","journal-title":"Ann Rheum Dis"},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010, 69: 1580-1588. 10.1136\/ard.2010.138461.","journal-title":"Ann Rheum Dis"},{"key":"483_CR13","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka T, Abelson B, Pincus T: Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008, 26: S35-S61.","journal-title":"Clin Exp Rheumatol"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/art.10419","volume":"46","author":"NJ Goodson","year":"2002","unstructured":"Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP: Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 2002, 46: 2010-2019. 10.1002\/art.10419.","journal-title":"Arthritis Rheum"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.2003.009530","volume":"63","author":"T Sokka","year":"2004","unstructured":"Sokka T, Hakkinen A, Krishnan E, Hannonen P: Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis. 2004, 63: 494-497. 10.1136\/ard.2003.009530.","journal-title":"Ann Rheum Dis"},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003, 107: 1303-1307. 10.1161\/01.CIR.0000054612.26458.B2.","journal-title":"Circulation"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1136\/ard.2009.110536","volume":"69","author":"G Tomasson","year":"2010","unstructured":"Tomasson G, Aspelund T, Jonsson T, Valdimarsson H, Felson DT, Gudnason V: Effect of rheumatoid factor on mortality and coronary heart disease. Ann Rheum Dis. 2010, 69: 1649-1654. 10.1136\/ard.2009.110536.","journal-title":"Ann Rheum Dis"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/art.23149","volume":"58","author":"TM Farragher","year":"2008","unstructured":"Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A: Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008, 58: 359-369. 10.1002\/art.23149.","journal-title":"Arthritis Rheum"},{"key":"483_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/art.30200","volume":"63","author":"MP van der Linden","year":"2011","unstructured":"van der Linden MP, Batstra MR, Bakker-Jonges LE, Detert J, Bastian H, Scherer HU, Toes RE, Burmester GR, Mjaavatten MD, Kvien TK, Huizinga TW, van der Helm-van Mil AH: Toward a data-driven evaluation of the 2010 American College of Rheumatology\/European League against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?. Arthritis Rheum. 2011, 63: 1190-1199. 10.1002\/art.30200.","journal-title":"Arthritis Rheum"},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/rheumatology\/33.8.735","volume":"33","author":"DP Symmons","year":"1994","unstructured":"Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ: The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994, 33: 735-739. 10.1093\/rheumatology\/33.8.735.","journal-title":"Br J Rheumatol"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"DP de Rooy","year":"2011","unstructured":"de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH: Predicting arthritis outcomes\u2013what can be learned from the Leiden Early Arthritis Clinic?. Rheumatology (Oxford). 2011, 50: 93-100. 10.1093\/rheumatology\/keq230.","journal-title":"Rheumatology (Oxford)"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3899\/jrheum.090188","volume":"36","author":"KP Liang","year":"2009","unstructured":"Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE: Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009, 36: 2462-2469. 10.3899\/jrheum.090188.","journal-title":"J Rheumatol"},{"key":"483_CR23","first-page":"2089","volume":"32","author":"S Sihvonen","year":"2005","unstructured":"Sihvonen S, Korpela M, Mustila A, Mustonen J: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005, 32: 2089-2094.","journal-title":"J Rheumatol"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10067-010-1557-5","volume":"29","author":"T Landmann","year":"2010","unstructured":"Landmann T, Kehl G, Bergner R: The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis. Clin Rheumatol. 2010, 29: 1449-1453. 10.1007\/s10067-010-1557-5.","journal-title":"Clin Rheumatol"},{"key":"483_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/ard.2006.068247","volume":"67","author":"SW Syversen","year":"2008","unstructured":"Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewe R, Kvien TK: High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 2008, 67: 212-217. 10.1136\/ard.2006.068247.","journal-title":"Ann Rheum Dis"},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/rheumatology\/keq190","volume":"50","author":"L Barra","year":"2011","unstructured":"Barra L, Pope J, Bessette L, Haraoui B, Bykerk V: Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford). 2011, 50: 311-316. 10.1093\/rheumatology\/keq190.","journal-title":"Rheumatology (Oxford)"},{"key":"483_CR28","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3899\/jrheum.110234","volume":"38","author":"MD Mjaavatten","year":"2011","unstructured":"Mjaavatten MD, van der Heijde DM, Uhlig T, Haugen AJ, Nygaard H, Bjorneboe O, Kvien TK: Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study. J Rheumatol. 2011, 38: 2336-2341. 10.3899\/jrheum.110234.","journal-title":"J Rheumatol"},{"key":"483_CR29","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar3834","volume":"14","author":"ML Burr","year":"2012","unstructured":"Burr ML, Viatte S, Bukhari M, Plant D, Symmons DP, Thomson W, Barton A: Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthritis Res Ther. 2012, 14: R109-10.1186\/ar3834.","journal-title":"Arthritis Res Ther"},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard.2008.100677","volume":"69","author":"V Nell-Duxneuner","year":"2010","unstructured":"Nell-Duxneuner V, Machold K, Stamm T, Eberl G, Heinzl H, Hoefler E, Smolen JS, Steiner G: Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study. Ann Rheum Dis. 2010, 69: 169-174. 10.1136\/ard.2008.100677.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0483-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0483-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:26:35Z","timestamp":1728923195000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0483-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0483-3","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,4]]},"assertion":[{"value":"28 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"483"}}